🇺🇸 L-Thyroxine in United States

1,888 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Nausea — 278 reports (14.72%)
  2. Fatigue — 246 reports (13.03%)
  3. Diarrhoea — 225 reports (11.92%)
  4. Dyspnoea — 195 reports (10.33%)
  5. Vomiting — 184 reports (9.75%)
  6. Drug Ineffective — 178 reports (9.43%)
  7. Headache — 150 reports (7.94%)
  8. Asthenia — 146 reports (7.73%)
  9. Dizziness — 143 reports (7.57%)
  10. Pyrexia — 143 reports (7.57%)

Source database →

L-Thyroxine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is L-Thyroxine approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for L-Thyroxine in United States?

Centre Hospitalier Universitaire, Amiens is the originator. The local marketing authorisation holder may differ — check the official source linked above.